Emergent Health Corp Stock Net Income
| EMGE Stock | USD 0.0003 0.00 0.00% |
As of the 17th of February 2026, Emergent Health shows the Mean Deviation of 8.86, variance of 793.12, and Standard Deviation of 28.16. Emergent Health Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Emergent Health Corp mean deviation, variance, as well as the relationship between the Variance and maximum drawdown to decide if Emergent Health Corp is priced favorably, providing market reflects its regular price of 3.0E-4 per share. As Emergent Health Corp appears to be a penny stock we also advise to verify its information ratio numbers.
Emergent Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Emergent Health's valuation are provided below:Emergent Health Corp does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Emergent |
Emergent Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Emergent Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Emergent Health.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Emergent Health on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Emergent Health Corp or generate 0.0% return on investment in Emergent Health over 90 days. Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals More
Emergent Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Emergent Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Emergent Health Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.132 | |||
| Maximum Drawdown | 200.0 |
Emergent Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emergent Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Emergent Health's standard deviation. In reality, there are many statistical measures that can use Emergent Health historical prices to predict the future Emergent Health's volatility.| Risk Adjusted Performance | 0.1182 | |||
| Jensen Alpha | 2.92 | |||
| Total Risk Alpha | 1.69 | |||
| Treynor Ratio | 0.2629 |
Emergent Health February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1182 | |||
| Market Risk Adjusted Performance | 0.2729 | |||
| Mean Deviation | 8.86 | |||
| Coefficient Of Variation | 743.49 | |||
| Standard Deviation | 28.16 | |||
| Variance | 793.12 | |||
| Information Ratio | 0.132 | |||
| Jensen Alpha | 2.92 | |||
| Total Risk Alpha | 1.69 | |||
| Treynor Ratio | 0.2629 | |||
| Maximum Drawdown | 200.0 | |||
| Skewness | 5.89 | |||
| Kurtosis | 39.14 |
Emergent Health Corp Backtested Returns
Emergent Health is out of control given 3 months investment horizon. Emergent Health Corp secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14 % return per unit of risk over the last 3 months. We were able to analyze and collect data for sixteen different technical indicators, which can help you to evaluate if expected returns of 4.1% are justified by taking the suggested risk. Use Emergent Health Variance of 793.12, standard deviation of 28.16, and Mean Deviation of 8.86 to evaluate company specific risk that cannot be diversified away. Emergent Health holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 14.37, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Emergent Health will likely underperform. Use Emergent Health variance, as well as the relationship between the maximum drawdown and rate of daily change , to analyze future returns on Emergent Health.
Auto-correlation | -0.3 |
Weak reverse predictability
Emergent Health Corp has weak reverse predictability. Overlapping area represents the amount of predictability between Emergent Health time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Emergent Health Corp price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Emergent Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Emergent Health Corp reported net income of 121.03 K. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 99.98% higher than that of the company.
Emergent Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emergent Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Emergent Health could also be used in its relative valuation, which is a method of valuing Emergent Health by comparing valuation metrics of similar companies.Emergent Health is currently under evaluation in net income category among its peers.
Emergent Fundamentals
| Return On Equity | -1.64 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (2.42) % | |||
| Operating Margin | (1.67) % | |||
| Current Valuation | 1.65 M | |||
| Shares Outstanding | 41.93 M | |||
| Price To Earning | (1.43) X | |||
| Price To Sales | 0.34 X | |||
| Revenue | 989.84 K | |||
| Gross Profit | 79.48 K | |||
| EBITDA | (179.57 K) | |||
| Net Income | 121.03 K | |||
| Cash And Equivalents | 496.69 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.27 % | |||
| Current Ratio | 9.55 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 76.97 K | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.41 | |||
| Market Capitalization | 222.23 K | |||
| Total Asset | 1.03 M | |||
| Retained Earnings | 471 K | |||
| Working Capital | 955 K | |||
| Current Asset | 1.03 M | |||
| Current Liabilities | 75 K | |||
| Net Asset | 1.03 M |
About Emergent Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Emergent Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emergent Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emergent Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Emergent Pink Sheet
Emergent Health financial ratios help investors to determine whether Emergent Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emergent with respect to the benefits of owning Emergent Health security.